PERSPECTA

News from every angle

Back to headlines

Judge Sets March 2027 Trial for Paramount-Warner Bros. Antitrust Suit

A judge has scheduled the antitrust trial concerning the proposed Paramount-Warner Bros. merger for March 2027. While David Ellison's team remains open to settlement, they express confidence in winning at trial.

4 Aug, 19:38 — 4 Aug, 23:24
PostShare

Source Diversity

Source Diversity

Moderate (42/100)
4 sources30/33
Spectrum spread2/5 buckets covered8/33
Far L1
Far Left (1)
NYT
Left3
Left (3)
deadlinehollywood-reportervariety
Center
Right
Far R
Geographic diversity1 region4/34
US4
All sources from US region

Sources

Showing 4 of 4 sources
NYTMostly Factual1d ago

Judge Sets Paramount-Warner Bros. Merger Trial for March

Paramount, which struck a $111 billion deal to acquire Warner Bros., had requested a November trial for an antitrust lawsuit brought by state attorneys general.

By Benjamin Mullin

Read full article →
varietyMostly Factual1d ago

Judge Sets Paramount-Warner Bros. Antitrust Trial for March 2027

The judge hearing the antitrust case seeking to block the Paramount-Warner Bros. Discovery merger has issued a preliminary scheduling order, with a trial set to start in March 2027 — considerably later than Paramount was hoping for. Judge Araceli Martinez-Olguin on Tuesday issued a ruling that said the trial will run a total of 12 […]

By Todd Spangler

Read full article →
hollywood-reporterMostly Factual1d ago

Paramount-Warner Bros. Trial to Start in March 2027 in Blow to David Ellison’s Team

The trial is set to begin roughly five months after Paramount starts paying a ticking fee of roughly $7 million per day to Warners shareholders.

By Winston Cho

Read full article →
deadlineMostly Factual1d ago

David Ellison Says Paramount Is “Absolutely Open” To Settling WBD Antitrust Suit, But “We Will Win At Trial”

Paramount CEO David Ellison says he is “absolutely open” to settling an antitrust lawsuit against the company’s pending merger with Warner Bros. Discovery but is also glad to proceed to a trial. Speaking for many during the company’s second-quarter earnings call, one Wall Street analyst asked what will happen if the pending $110 billion deal […]

By Dade Hayes

Read full article →